OMX Nordic 40
2 298,46
|
5,44
|
0,24 %
|
Analysen zu OMX Nordic 40-Werten
11.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
11.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
10.07.24 | AstraZeneca Hold | Deutsche Bank AG | |
10.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
10.07.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
09.07.24 | Hennes & Mauritz AB Underperform | Bernstein Research | |
09.07.24 | Ericsson Neutral | JP Morgan Chase & Co. | |
08.07.24 | Volvo AB Buy | Jefferies & Company Inc. | |
08.07.24 | ABB Neutral | JP Morgan Chase & Co. | |
08.07.24 | Hennes & Mauritz AB Outperform | RBC Capital Markets | |
08.07.24 | Volvo AB Sector Perform | RBC Capital Markets | |
08.07.24 | ABB Sector Perform | RBC Capital Markets | |
04.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
04.07.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
04.07.24 | Nokia Neutral | UBS AG | |
04.07.24 | Volvo AB Buy | Goldman Sachs Group Inc. | |
04.07.24 | ABB Buy | Goldman Sachs Group Inc. | |
03.07.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.07.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.07.24 | Nokia Hold | Jefferies & Company Inc. | |
03.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
03.07.24 | Hennes & Mauritz AB Buy | Deutsche Bank AG | |
02.07.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
02.07.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
01.07.24 | Volvo AB Buy | Jefferies & Company Inc. | |
01.07.24 | Hennes & Mauritz AB Outperform | RBC Capital Markets | |
01.07.24 | Nokia Neutral | UBS AG | |
01.07.24 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
28.06.24 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
28.06.24 | Nokia Neutral | Goldman Sachs Group Inc. | |
28.06.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
28.06.24 | Novo Nordisk Neutral | UBS AG | |
28.06.24 | Hennes & Mauritz AB Buy | UBS AG | |
27.06.24 | ABB Hold | Jefferies & Company Inc. | |
27.06.24 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
27.06.24 | Hennes & Mauritz AB Outperform | RBC Capital Markets | |
27.06.24 | Hennes & Mauritz AB Buy | UBS AG | |
27.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
27.06.24 | Hennes & Mauritz AB Sell | Deutsche Bank AG | |
27.06.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. |